The HCPLive Psychiatry condition center page is a comprehensive resource for clinical news and insights on mental illnesses. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for depression, schizophrenia, bipolar disorder, anxiety, and more.

Latest News

Phase 3 Data Shows Lumateperone Delays Schizophrenia Relapse Longer Than Placebo
Phase 3 Data Shows Lumateperone Delays Schizophrenia Relapse Longer Than Placebo

November 6th 2024

Phase 3 data shows lumateperone 42 mg significantly delayed relapse in patients with schizophrenia vs placebo, with 63% reduced relapse risk and good tolerance.

Phase 3 Data Shows TEV-‘749 Injection Improves Social Function in Schizophrenia
Phase 3 Data Shows TEV-‘749 Injection Improves Social Function in Schizophrenia

November 6th 2024

SPN-820 Decreases Depressive Symptoms Within Hours of First Dose in Phase 2a Trial
SPN-820 Decreases Depressive Symptoms Within Hours of First Dose in Phase 2a Trial

November 1st 2024

Psychiatry Month in Review: October 2024
Psychiatry Month in Review: October 2024

November 1st 2024

Bristol Myers Squibb Shares EMERGENT-4, EMERGENT-5 Results on Cobenfy for Schizophrenia
Bristol Myers Squibb Shares EMERGENT-4, EMERGENT-5 Results on Cobenfy for Schizophrenia

November 1st 2024

More News

© 2024 MJH Life Sciences

All rights reserved.